Episode 42 - David De Graaf, CEO of Reverb Therapeutics episode artwork

EPISODE · Apr 2, 2025 · 27 MIN

Episode 42 - David De Graaf, CEO of Reverb Therapeutics

from The BioHub: The Top Voices in Biotech · host Max Brennan - Biotech HeadHunter

Welcome to the BioHub podcast where we interview the top minds from across the Biotech and Pharma industry.Today we're joined by David De Graaf, CEO of Co-Founder of Reverb TherapeuticsDavid has an incredible background, with positions at companies such as AstraZeneca, Pfizer, Apple Tree Partners & Boehringer Ingelheim as well being at the helm of multiple successful biotechs. In this episode, we dive into his journey, building out seed stage biotech's from scratch as well as the Canadian Biotech scene

Episode metadata supplied by the publisher feed · Published Apr 2, 2025

Embed this episode

NOW PLAYING

Episode 42 - David De Graaf, CEO of Reverb Therapeutics

0:00 27:26

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of The BioHub: The Top Voices in Biotech?

This episode is 27 minutes long.

When was this The BioHub: The Top Voices in Biotech episode published?

This episode was published on April 2, 2025.

Can I download this The BioHub: The Top Voices in Biotech episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!